Biomerica Inc. (BMRA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Biomerica Inc. (BMRA:NASDAQ), powered by AI.

Current Price
$2.05
P/E Ratio
-0.9
Market Cap
5M
Sector
Healthcare
What is the Biomerica Inc. stock price forecast?

Biomerica Inc. is currently trading at $2.05. View real-time AI analysis on Alpha Lenz.

What is Biomerica Inc. insider trading activity?

View the latest insider trading data for Biomerica Inc. on Alpha Lenz.

What is Biomerica Inc.'s P/E ratio?

Biomerica Inc.'s P/E ratio is -0.9.

Biomerica Inc.

NASDAQ · BMRA
$2.05-0.04(-1.91%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Biomerica Inc.'s future dividend policy...
Alpha Chat Insight

Biomerica Inc. trades at a P/E of -0.9 (undervalued) with modest ROE of -93.0%.

Ask for details

Company Overview

Biomerica Inc. operates within the healthcare sector as a developer and manufacturer of advanced medical diagnostic products. The primary function of Biomerica Inc. is to innovate in the realm of diagnostic testing, with a focus on chronic diseases and conditions. Their portfolio includes products designed for the early detection and management of illnesses such as diabetes, gastrointestinal disorders, and various forms of cancer. Through its cutting-edge technology, Biomerica Inc. aims to improve patient care by offering precise and reliable testing solutions that can be utilized in clinical laboratories, hospitals, and research institutions. Biomerica's work significantly impacts the healthcare industry by catering to the rising demand for efficient diagnostic tools that help in timely disease intervention. Based in Irvine, California, and with a global presence, Biomerica Inc. positions itself as a pivotal player in enhancing healthcare delivery and contributing to clinical advancements by providing products that drive better health outcomes.

CEOMr. Zackary S. Irani
SectorHealthcare
IndustryMedical Devices
Employees53

Company Statistics

FY 2025

Profile

$4.71MMarket Cap
$5.31MRevenue
0.00Shares Out
53Employees

Margins

9.38%Gross
-89.19%EBITDA
-96.72%Operating
-93.62%Pre-Tax
-93.64%Net

Valuation

-0.95P/E
1.15P/B
0.89EV/Sales
-0.58EV/EBITDA
-1.21P/FCF

Growth (CAGR)

-34.47%Rev 3Yr
-4.52%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-65.44%ROA
-92.99%ROE
-67.60%ROIC

Financial Health

$2.40MCash & Cash Equivalents
$-559.00KNet Debt
44.82%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Biomerica Inc. (ticker: BMRA) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 53 employees. Market cap is $5M.

The current price is $2.05 with a P/E ratio of -0.95x and P/B of 1.15x.

ROE is -92.99% and operating margin is -96.72%. Annual revenue is $5M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Biomerica Inc. (BMRA) Stock Forecast 2026 $2.05 — Price, Financials & Analyst Targets | Alpha Lenz